Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
J. Rastad, E. Lundgren, S. Ljunghall.
Clinical presentation of primary hyperparathyroidism.
The parathyroids 2 nd e.d7, pp. 361-374
[2.]
Consensus Development Conference Panel.
Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference Statement.
Ann Intern Med, 114 (1991), pp. 593-597
[3.]
S.J. Silverberg, E. Shane, T.P. Jacobs, E. Siris, J.P. Bilezikian.
A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.
N Engl J Med, 341 (1999), pp. 1249-1255
[4.]
S.J. Silverberg, I. Brown, J.P. Bilezikian.
Age as criterion for surgery in primary hyperparathyroidism.
Am J Med, 113 (2002), pp. 681-683
[5.]
R.D. Utiger.
Treatment of primary hyperparathyroidism.
N Engl J Med, 341 (1999), pp. 1301-1302
[6.]
S.J. Silverberg, J.P. Bilezikian, H.G. Bone, G.B. Talpos, M.J. Horwitz, A.F. Stewart.
Therapeutic controversies in primary hyperparathyroidism.
J Clin Endocrinol Metab, 84 (1999), pp. 2275-2285
[7.]
S. Khosla, L.J. Melton III.
Fracture risk in primary hyperparathyroidism.
J Bone Miner Res, 17 (2002), pp. N103-N107
[8.]
J.C. Smith, D. Page, M.H. Wheeler, J.R. Cockcroft, M.F. Scanlon, J.S. Davies.
Augmentation of central arterial pressure in mild hyperparathyroidism.
J Clin Endocrinol Metab, 85 (2000), pp. 3515-3519
[9.]
T. Stefenelli, C. Abela, H. Frank, J. Koller-Strametz, S. Globits, J. Bergler-Klein, et al.
Cardiac abnormalities in patients with primary hyperparathyroidism; implications for follow-up.
J Clin Endocrinol Metab, 82 (1997), pp. 106-112
[10.]
J.P. Bilezikian, J.T. Potts.
Asymptomatic primary hyperparathyroidism: new issues and new questions-bridging the past with the future.
J Bone Miner Res, 17 (2002), pp. N57-N67
[11.]
J.P. Bilezikian, J.T. Potts, H. Fuleihan Gel, M. Kleerekoper, R. Neer, M. Peacock, et al.
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.
J Bone Miner Res, 17 (2002), pp. N2-N11
[12.]
S.J. Silverberg, F.G. Locker, J.P. Bilezikian.
Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism.
J Clin Endocrinol Metab, 81 (1996), pp. 4007-4012
[13.]
S.J. Silverberg, I.I.I. Bone HG, T.B. Marriott, F.G. Locker, S.T. Thys-Jacobs, G. Dziem, et al.
Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism.
N Engl J Med, 337 (1997), pp. 1506-1510
[14.]
J.M. Frazao, P. Martins, J.W. Coburn.
The calcimimetic agents: perspectives for treatment.
Kidney Int, 61 (2002), pp. S149-S154
[15.]
H. Chen, L.J. Sokoll, R. Udelsman.
Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay.
Surgery, 126 (1999), pp. 1016-1022
[16.]
A.C. Civelek, E. Ozalp, P. Donovan, R. Udelsman.
Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism.
Surgery, 131 (2002), pp. 149-157
[17.]
J.M. Monchik, L. Barellini, P. Langer, A. Kahya.
Minimally invasive parathyroid surgery in 103 patients with local/regional anesthesia, without exclusion criteria.
Surgery, 131 (2002), pp. 502-508
[18.]
A. Bergenfelz, P. Lindblom, S. Tibblin, J. Westerdahl.
Unilateral versus bilateral neck exploration for primary hyperparathyroidism. A prospective randomised controlled trial.
Ann Surg, 236 (2002), pp. 543-551
[19.]
N.D. Perrier, P.G. Ituarte, E. Morita, T. Hamill, R. Gielow, Q.Y. Duh, et al.
Parathyroid surgery: separating promise from reality.
J Clin Endocrinol Metab, 87 (2002), pp. 1024-1029
[20.]
E. Vignali, A. Picone, G. Materazzi, S. Steffé, P. Berti, L. Cianferotti, et al.
A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases.
Eur J Endocrinol, 146 (2002), pp. 783-788
[21.]
P.C. Kao, J.A. Van Heerden, D.R. Farley, G.B. Thompson, R.L. Taylor.
Intraoperative monitoring of parathyroid hormone with a rapid automated assay that is commercially available.
Ann Clin Lab Sci, 32 (2002), pp. 244-251
[22.]
J. Westerdahl, P. Lindblom, A. Bergenfelz.
Measurement of intraoperative parathyroid hormone long-term operative success.
Arch Surg, 137 (2002), pp. 186-190
Copyright © 2004. Sociedad Española de Endocrinología y Nutrición